Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.120
+0.090 (4.43%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Cassava Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 102 | 114 | 949 | 1,233 | 1,749 | 238 | |
| Market Cap Growth | -16.52% | -88.04% | -22.98% | -29.52% | 633.58% | 166.23% | |
| Enterprise Value | -4 | -35 | 807 | 1,058 | 1,507 | 215 | |
| Last Close Price | 2.12 | 2.36 | 22.51 | 29.54 | 43.70 | 6.82 | |
| Forward PE | - | - | 68.21 | - | - | 82.67 | |
| PB Ratio | 1.26 | 0.78 | 6.91 | 5.42 | 6.89 | 2.59 | |
| P/TBV Ratio | 1.26 | 0.78 | 6.92 | 5.43 | 6.92 | 2.59 | |
| Debt / Equity Ratio | - | - | - | 0.00 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -1.30 | -0.88 | -0.88 | -0.88 | -0.92 | -1.01 | |
| Net Debt / EBITDA Ratio | 1.53 | 0.92 | 1.16 | 2.55 | 7.21 | 13.77 | |
| Net Debt / FCF Ratio | 1.26 | 1.10 | 1.47 | 2.50 | 4.45 | 17.32 | |
| Quick Ratio | 2.23 | 11.02 | 8.60 | 28.46 | 18.62 | 50.14 | |
| Current Ratio | 2.27 | 11.62 | 9.13 | 29.91 | 19.51 | 50.40 | |
| Return on Equity (ROE) | -85.44% | -17.19% | -53.27% | -31.67% | -18.71% | -11.08% | |
| Return on Assets (ROA) | -24.80% | -57.18% | -34.27% | -19.94% | -11.38% | -7.21% | |
| Return on Capital Employed (ROCE) | -85.80% | -97.00% | -77.10% | -35.10% | -12.90% | -7.30% | |
| Earnings Yield | -103.53% | -21.44% | -10.24% | -6.19% | -1.85% | -2.66% | |
| FCF Yield | -81.93% | -103.08% | -8.68% | -6.51% | -3.00% | -2.26% | |
| Buyback Yield / Dilution | -7.58% | -11.14% | -4.30% | -2.02% | -50.95% | -49.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.